{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neoplasms%2C+Basal+Cell&page=7", "query": { "condition": "Neoplasms, Basal Cell", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 244, "total_pages": 25, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neoplasms%2C+Basal+Cell&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neoplasms%2C+Basal+Cell&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T11:01:43.699Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07227870", "title": "L19IL2/TNF in Patients With Basal Cell Carcinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Locally Advanced Basal Cell Carcinoma" ], "interventions": [ { "name": "L19IL2/L19TNF", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Philogen S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 92, "start_date": "2026-09", "completion_date": "2031-02", "has_results": false, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 5, "location_summary": "Tampa, Florida • Atlanta, Georgia • New York, New York + 2 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227870" }, { "nct_id": "NCT06368817", "title": "A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Basal Ganglia Germinoma", "Diabetes Insipidus", "Germinoma", "Pineal Region Germinoma", "Suprasellar Germinoma", "Thalamic Germinoma" ], "interventions": [ { "name": "3-Dimensional Conformal Proton Radiation Therapy", "type": "RADIATION" }, { "name": "3-Dimensional Conformal Radiation Therapy", "type": "RADIATION" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Intensity-Modulated Proton Therapy", "type": "PROCEDURE" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Lumbar Puncture", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Surgical Procedure", "type": "PROCEDURE" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "3 Years to 29 Years" }, "enrollment_count": 240, "start_date": "2024-10-22", "completion_date": "2033-11-04", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 97, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 76 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06368817" }, { "nct_id": "NCT00314756", "title": "Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Basal Cell Carcinoma" ], "interventions": [ { "name": "imiquimod", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2005-03", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2023-08-22", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00314756" }, { "nct_id": "NCT01201915", "title": "A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Basal Cell Carcinoma" ], "interventions": [ { "name": "Vismodegib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 74, "start_date": "2010-10", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2014-06-24", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Redwood City, California + 9 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01201915" }, { "nct_id": "NCT01700049", "title": "Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Basal Cell Carcinoma" ], "interventions": [ { "name": "vismodegib (150 mg PO daily)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2013-01-14", "completion_date": "2018-07-03", "has_results": true, "last_update_posted_date": "2019-05-23", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01700049" }, { "nct_id": "NCT05188729", "title": "Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Basal Cell Carcinoma", "Skin Cancer", "Cancer of the Skin, Basal Cell", "Cancer of the Skin", "Carcinoma" ], "interventions": [ { "name": "Part 1: VP-315 3 Day Dosing/Week", "type": "DRUG" }, { "name": "Part 2: VP-315 3 Day Dosing/Week - Loading Dose", "type": "DRUG" }, { "name": "Part 2: VP-315 3 Day Dosing/Week - No Loading Dose", "type": "DRUG" }, { "name": "Part 2: VP-315 2 Day Dosing/Week - Split Dose", "type": "DRUG" }, { "name": "Part 2: VP-315 3 Day Dosing/Week - Split Dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Verrica Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 92, "start_date": "2022-02-01", "completion_date": "2024-04-15", "has_results": true, "last_update_posted_date": "2025-06-18", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 13, "location_summary": "San Diego, California • Boca Raton, Florida • Coral Springs, Florida + 9 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Coral Springs", "state": "Florida" }, { "city": "Saint Augustine", "state": "Florida" }, { "city": "Snellville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05188729" }, { "nct_id": "NCT01835626", "title": "Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Locally Advanced Basal Cell Carcinoma", "Skin Cancer", "Cutaneous Malignancy" ], "interventions": [ { "name": "Vismodegib", "type": "DRUG" }, { "name": "Radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Sue Yom", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2013-05", "completion_date": "2019-09-10", "has_results": true, "last_update_posted_date": "2021-05-03", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 2, "location_summary": "San Francisco, California • New York, New York", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01835626" }, { "nct_id": "NCT04928222", "title": "Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Basal Cell Carcinoma" ], "interventions": [ { "name": "Doxorubicin-containing MNA", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo-containing MNA", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "SkinJect, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 25, "start_date": "2021-09-24", "completion_date": "2024-06-30", "has_results": false, "last_update_posted_date": "2023-04-14", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 2, "location_summary": "West Palm Beach, Florida • New York, New York", "locations": [ { "city": "West Palm Beach", "state": "Florida" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04928222" }, { "nct_id": "NCT00476905", "title": "Spectral Diagnosis of Cutaneous Malignancy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Skin Cancer" ], "interventions": [ { "name": "Spectral Diagnosis Probe", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2007-04", "completion_date": "2018-11-20", "has_results": false, "last_update_posted_date": "2019-05-20", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00476905" }, { "nct_id": "NCT00586040", "title": "Photochemical Tissue Bonding", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Basal Cell Carcinoma", "Squamous Cell Carcinoma", "Atypical Nevus" ], "interventions": [ { "name": "tissue bonding", "type": "PROCEDURE" }, { "name": "sutures", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "20 Years to 60 Years" }, "enrollment_count": 40, "start_date": "2007-09", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2009-04-10", "last_synced_at": "2026-10-05T11:01:43.699Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00586040" } ] }